Unknown

Dataset Information

0

Glycoproteomic and Phenotypic Elucidation of B4GALNT2 Expression Variants in the SID Histo-Blood Group System.


ABSTRACT: The Sda histo-blood group antigen (GalNAcβ1-4(NeuAcα2-3)Galβ-R) is implicated in various infections and constitutes a potential biomarker for colon cancer. Sd(a−) individuals (2−4% of Europeans) may produce anti-Sda, which can lead to incompatible blood transfusions, especially if donors with the high-expressing Sd(a++)/Cad phenotype are involved. We previously reported the association of B4GALNT2 mutations with Sd(a−), which established the SID blood-group system. The present study provides causal proof underpinning this correlation. Sd(a−) HEK293 cells were transfected with different B4GALNT2 constructs and evaluated by immunostaining and glycoproteomics. The predominant SIDnull candidate allele with rs7224888:T>C (p.Cys406Arg) abolished Sda synthesis, while this antigen was detectable as N- or O-glycans on glycoproteins following transfection of wildtype B4GALNT2. Surprisingly, two rare missense variants, rs148441237:A>G and rs61743617:C>T, found in a Sd(a−) compound heterozygote, gave results similar to wildtype. To elucidate on whether Sd(a++)/Cad also depends on B4GALNT2 alterations, this gene was sequenced in five individuals. No Cad-specific changes were identified, but a detailed erythroid Cad glycoprotein profile was obtained, especially for glycophorin-A (GLPA) O-glycosylation, equilibrative nucleoside transporter 1 (S29A1) O-glycosylation, and band 3 anion transport protein (B3AT) N-glycosylation. In conclusion, the p.Cys406Arg β4GalNAc-T2 variant causes Sda-deficiency in humans, while the enigmatic Cad phenotype remains unresolved, albeit further characterized.

SUBMITTER: Stenfelt L 

PROVIDER: S-EPMC8999409 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Glycoproteomic and Phenotypic Elucidation of <i>B4GALNT2</i> Expression Variants in the SID Histo-Blood Group System.

Stenfelt Linn L   Nilsson Jonas J   Hellberg Åsa Å   Liew Yew Wah YW   Morrison Jenny J   Larson Göran G   Olsson Martin L ML  

International journal of molecular sciences 20220401 7


The Sda histo-blood group antigen (GalNAcβ1-4(NeuAcα2-3)Galβ-R) is implicated in various infections and constitutes a potential biomarker for colon cancer. Sd(a−) individuals (2−4% of Europeans) may produce anti-Sda, which can lead to incompatible blood transfusions, especially if donors with the high-expressing Sd(a++)/Cad phenotype are involved. We previously reported the association of B4GALNT2 mutations with Sd(a−), which established the SID blood-group system. The present study provides cau  ...[more]

Similar Datasets

2022-04-07 | PXD023943 | Pride
| S-EPMC3141052 | biostudies-literature
| S-EPMC11041853 | biostudies-literature
| S-EPMC4338890 | biostudies-literature
| S-EPMC4317100 | biostudies-literature
| S-EPMC7117023 | biostudies-literature
| S-EPMC4489644 | biostudies-literature
| S-EPMC3149758 | biostudies-literature
| S-EPMC6656718 | biostudies-literature
| S-EPMC4894678 | biostudies-literature